Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
BeOne Medicines
University of Washington
AstraZeneca
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Acerta Pharma BV
Acerta Pharma BV
AstraZeneca
Ohio State University Comprehensive Cancer Center
Acerta Pharma BV
Fred Hutchinson Cancer Center
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Acerta Pharma BV
City of Hope Medical Center
University of Washington
Dana-Farber Cancer Institute
University of California, San Diego
Acerta Pharma BV
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Northwestern University
City of Hope Medical Center
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)